Gainers
- Protagenic Therapeutics PTIX stock rose 21.4% to $0.78 during Tuesday's after-market session. The market value of their outstanding shares is at $3.4 million.
- Talphera TLPH shares increased by 11.7% to $1.05. The market value of their outstanding shares is at $17.8 million.
- Context Therapeutics CNTX shares rose 8.49% to $2.17. The market value of their outstanding shares is at $162.7 million.
- Fortrea Holdings FTRE shares rose 6.68% to $18.99. The company's market cap stands at $1.7 billion.
- Genelux GNLX stock rose 6.15% to $2.76. The market value of their outstanding shares is at $95.3 million.
- ENDRA Life Sciences NDRA stock rose 5.26% to $0.44. The company's market cap stands at $7.9 million.
Losers
- TELA Bio TELA shares declined by 15.7% to $2.1 during Tuesday's after-market session. The market value of their outstanding shares is at $51.8 million.
- Ensysce Biosciences ENSC shares declined by 11.45% to $0.48. The company's market cap stands at $6.6 million.
- Genprex GNPX stock decreased by 10.59% to $3.21. The market value of their outstanding shares is at $8.3 million.
- Allakos ALLK stock declined by 6.72% to $1.25. The market value of their outstanding shares is at $111.0 million.
- Sensei Biotherapeutics SNSE shares declined by 6.71% to $0.58. The company's market cap stands at $14.5 million.
- TuHURA Biosciences HURA stock decreased by 6.67% to $4.9. The market value of their outstanding shares is at $205.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
CNTXContext Therapeutics Inc
$1.3023.8%
ENSCEnsysce Biosciences Inc
$8.251.35%
FTREFortrea Holdings Inc
$18.65-%
GNLXGenelux Corp
$2.32-1.69%
GNPXGenprex Inc
$0.86271.30%
HURATuHURA Biosciences Inc
$4.02-1.71%
NDRAENDRA Life Sciences Inc
$6.14-1.92%
PTIXProtagenic Therapeutics Inc
$0.51004.08%
SNSESensei Biotherapeutics Inc
$0.52607.33%
TELATELA Bio Inc
$3.143.97%
TLPHTalphera Inc
$0.57108.95%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in